A company focused on discovery and development of biotherapeutics for treatment of vascular diseases.
A leading clinical research company, located in Leonia, New Jersey, U.S.A. We specialize in providing high quality and expedient early phase drug development services.
Development of proprietary, late stage pharmaceutical products that add market value and clinical benefit to existing drugs.
25 years in successfully developing, designing, producing, selling and marketing a complete line of diagnostics reagents and kits for use in hospitals, medical laboratories, research institutions and the health care and pharmaceutical industries.
A leading provider of integrated drug discovery services to the Pharmaceutical and Biotechnology sectors.
Cytomyx provides its clients in the pharma-biotech and life-science communities with a complete range of genomic and proteomic discovery research services and reagents.
Research and development biotechnology company specializing in treatments for type 2 diabetes and obesity.
A privately held drug discovery company developing drugs to treat age-dependent diseases, with an initial focus on cancer and cardiovascular disorders.
Isolating and identifying hibernation-related peptides that can become therapies for stroke, heart disease, high blood pressure, obesity, cancerous tumors, kidney failure and other human diseases.
A division of the Department of Pharmceutics at Rutgers University which conducts preclinical studies in absorption, metabolism, distribution, and excretion (ADME) assessment of new chemical entities and of existing drug compounds incorporated into drug delivery vehicles.
|